Cervical cancer risk factors among HIV-infected Nigerian women

被引:36
作者
Ononogbu, Uzoma [1 ]
Almujtaba, Maryam [2 ]
Modibbo, Fatima [3 ]
Lawal, Ishak [4 ]
Offiong, Richard [4 ]
Olaniyan, Olayinka [3 ]
Dakum, Patrick [2 ]
Spiegelman, Donna [1 ,5 ]
Blattner, William [6 ,7 ]
Adebamowo, Clement [2 ,6 ,7 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Inst Human Virol, Off Res & Training, Abuja, Nigeria
[3] Natl Hosp, Abuja, Nigeria
[4] Univ Abuja, Teaching Hosp, Gwagwalada, Nigeria
[5] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[6] Univ Maryland, Sch Med, Inst Human Virol, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
[7] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
Cervical cancer; Screen and treat; HIV; VIA/VILI; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; VIRAL LOAD; IMMUNODEFICIENCY; PREVALENCE; PREVENTION; AFRICA; POPULATION; WORLDWIDE;
D O I
10.1186/1471-2458-13-582
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Cervical cancer is the third most common cancer among women worldwide, and in Nigeria it is the second most common female cancer. Cervical cancer is an AIDS-defining cancer; however, HIV only marginally increases the risk of cervical pre-cancer and cancer. In this study, we examine the risk factors for cervical pre-cancer and cancer among HIV-positive women screened for cervical cancer at two medical institutions in Abuja, Nigeria. Methods: A total of 2,501 HIV-positive women participating in the cervical cancer screen-and-treat program in Abuja, Nigeria consented to this study and provided socio-demographic and clinical information. Log-binomial models were used to calculate relative risk (RR) and 95% confidence intervals (95% CI) for the risk factors of cervical pre-cancer and cancer. Results: There was a 6% prevalence of cervical pre-cancer and cancer in the study population of HIV-positive women. The risk of screening positivity or invasive cancer diagnosis reduced with increasing age, with women aged 40 years and older having the lowest risk (RR=0.4; 95% CI=0.2-0.7). Women with a CD4 count of 650 per mm(3) or more also had lower risk of screening positivity or invasive cancer diagnosis (RR=0.3, 95% CI=0.2-0.6). Other factors such as having had 5 or more abortions (RR=1.8, 95% CI=1.0-3.6) and the presence of other vaginal wall abnormalities (RR=1.9, 95% CI=1.3-2.8) were associated with screening positivity or invasive cancer diagnosis. Conclusion: The prevalence of screening positive lesions or cervical cancer was lower than most previous reports from Africa. HIV-positive Nigerian women were at a marginally increased risk of cervical pre-cancer and cancer. These findings highlight the need for more epidemiological studies of cervical cancer and pre-cancerous lesions among HIV-positive women in Africa and an improved understanding of incidence and risk factors.
引用
收藏
页数:10
相关论文
共 53 条
[11]  
Brinton LA, 2006, CANCER, V76, P1888
[12]   CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus [J].
Cardillo, M ;
Hagan, R ;
Abadi, J ;
Abadi, MA .
CANCER CYTOPATHOLOGY, 2001, 93 (02) :111-114
[13]   Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention [J].
Castellsagué, X ;
Díaz, M ;
de Sanjosé, S ;
Muñoz, N ;
Herrero, R ;
Franceschi, S ;
Peeling, RW ;
Ashley, R ;
Smith, JS ;
Snijders, PJF ;
Meijer, CJLM ;
Bosch, FX .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :303-315
[14]  
Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20
[15]   Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Plummer, M ;
Muñoz, N ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 88 (01) :63-73
[16]   Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].
Clifford, GM ;
Polesel, J ;
Rickenbach, M ;
Dal Maso, L ;
Keiser, O ;
Kofler, A ;
Rapiti, E ;
Levi, F ;
Jundt, G ;
Fisch, T ;
Bordoni, A ;
De Weck, D ;
Franceschi, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432
[17]   Pattern of cancer risk in persons with AIDS in Italy in the HAART era [J].
Dal Maso, L. ;
Polesel, J. ;
Serraino, D. ;
Lise, M. ;
Piselli, P. ;
Falcini, F. ;
Russo, A. ;
Intrieri, T. ;
Vercelli, M. ;
Zambon, P. ;
Tagliabue, G. ;
Zanetti, R. ;
Federico, M. ;
Limina, R. M. ;
Mangone, L. ;
De Lisi, V. ;
Stracci, F. ;
Ferretti, S. ;
Piffer, S. ;
Budroni, M. ;
Donato, A. ;
Giacomin, A. ;
Bellu, F. ;
Fusco, M. ;
Madeddu, A. ;
Vitarelli, S. ;
Tessandori, R. ;
Tumino, R. ;
Suligoi, B. ;
Franceschi, S. .
BRITISH JOURNAL OF CANCER, 2009, 100 (05) :840-847
[18]   HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy [J].
De Vuyst, Hugo ;
Lillo, Flavia ;
Broutet, Nathalie ;
Smith, Jennifer S. .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2008, 17 (06) :545-554
[19]   Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa [J].
De Vuyst, Hugo ;
Ndirangu, Gathari ;
Moodley, Manivasan ;
Tenet, Vanessa ;
Estambale, Benson ;
Meijer, Chris J. L. M. ;
Snijders, Peter J. F. ;
Clifford, Gary ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) :949-955
[20]   Screening for cervical cancer in developing countries [J].
Denny, Lynette ;
Quinn, Michael ;
Sankaranarayanan, R. .
VACCINE, 2006, 24 :71-77